source
- Kairon Health raises $5M to turn patient data into actionable to‑do lists for value‑based care practicesKairon Health, a health‑tech startup, offers a platform that aggregates patient information from claims, electronic health records and pharmacy data and converts it into actionable to‑do lists for…
- Summit and Akeso report ivonescimab extends lung cancer survival by eight months versus Keytruda in Phase 3 trialSummit Therapeutics and its partner Akeso said their experimental dual-target drug ivonescimab added about eight months of overall survival for patients with lung cancer compared with Merck's Keytr…